FDAnews
www.fdanews.com/articles/61062-elan-sues-abraxis-bioscience-for-patent-infringement

ELAN SUES ABRAXIS BIOSCIENCE FOR PATENT INFRINGEMENT

July 20, 2006

Irish drug maker Elan Corp. has accused rival Abraxis Bioscience Inc. of infringing its patents by selling the breast cancer treatment Abraxane. A lawsuit filed Wednesday in a Delaware federal court says Abraxane, a nano-particle formulation of paclitaxel, trespasses on two patents issued in the 1990s that cover methods of formulating anti cancer drugs.
Market Watch